Spotlight On: Looking beyond Plavix for evidence of Lipitor type post expiry strategies

•

0 j'aime•479 vues

Spotlight On: Looking beyond Plavix for evidence of Lipitor type post expiry strategies

Recommandé

$Payers likely to throw up hurdles to Pfizer\'s new RA drug$ $Payers likely to throw up hurdles to Pfizer\'s new RA drug$

Payers likely to throw up hurdles to Pfizer\'s new RA drug

Rhonda Greenapple

$How Payers View Pfizer\'s Rheumatoid Arthritis Pill$ $How Payers View Pfizer\'s Rheumatoid Arthritis Pill$

How Payers View Pfizer\'s Rheumatoid Arthritis Pill

Rhonda Greenapple

Vbcc Aco Article

Rhonda Greenapple

First Word Pharma View Points Commercial Prospects In The Obesity Market ...

Rhonda Greenapple

Analysis: Drug Costs Become Bigger Issue In Cancer Care

Rhonda Greenapple

$View Points: Could Pfizer\'s tofacitinib beat expectation and gain approval ...$ $View Points: Could Pfizer\'s tofacitinib beat expectation and gain approval ...$

View Points: Could Pfizer\'s tofacitinib beat expectation and gain approval ...

Rhonda Greenapple

AHDB_Payers Collaborate with Providers To Adopt Oncology Pathways, New Care D...

Rhonda Greenapple

Looking beyond Plavix for evidence of Lipitor-type post-expiry strategies

Rhonda Greenapple

Recommandé

$Payers likely to throw up hurdles to Pfizer\'s new RA drug$ $Payers likely to throw up hurdles to Pfizer\'s new RA drug$

Payers likely to throw up hurdles to Pfizer\'s new RA drug

Rhonda Greenapple

$How Payers View Pfizer\'s Rheumatoid Arthritis Pill$ $How Payers View Pfizer\'s Rheumatoid Arthritis Pill$

How Payers View Pfizer\'s Rheumatoid Arthritis Pill

Rhonda Greenapple

Vbcc Aco Article

Rhonda Greenapple

First Word Pharma View Points Commercial Prospects In The Obesity Market ...

Rhonda Greenapple

Analysis: Drug Costs Become Bigger Issue In Cancer Care

Rhonda Greenapple

$View Points: Could Pfizer\'s tofacitinib beat expectation and gain approval ...$ $View Points: Could Pfizer\'s tofacitinib beat expectation and gain approval ...$

View Points: Could Pfizer\'s tofacitinib beat expectation and gain approval ...

Rhonda Greenapple

AHDB_Payers Collaborate with Providers To Adopt Oncology Pathways, New Care D...

Rhonda Greenapple

Looking beyond Plavix for evidence of Lipitor-type post-expiry strategies

Rhonda Greenapple

Why Pfizers Rheumatoid Arthritis Pill May Not Be A Sure Bet

Rhonda Greenapple

Pfizer’s Rheumatoid Arthritis Pill Not A Slam Dunk

Rhonda Greenapple

Pfizer Tactics To Combat Generic Drugmakers Financial Times Dec 5, 2011

Rhonda Greenapple